These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 22888239)

  • 1. Bufalin-loaded mPEG-PLGA-PLL-cRGD nanoparticles: preparation, cellular uptake, tissue distribution, and anticancer activity.
    Yin P; Wang Y; Qiu Y; Hou L; Liu X; Qin J; Duan Y; Liu P; Qiu M; Li Q
    Int J Nanomedicine; 2012; 7():3961-9. PubMed ID: 22888239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. cRGD-functionalized mPEG-PLGA-PLL nanoparticles for imaging and therapy of breast cancer.
    Liu P; Qin L; Wang Q; Sun Y; Zhu M; Shen M; Duan Y
    Biomaterials; 2012 Oct; 33(28):6739-47. PubMed ID: 22763223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. cRGD conjugated mPEG-PLGA-PLL nanoparticles for SGC-7901 gastric cancer cells-targeted Delivery of fluorouracil.
    Liu P; Wang H; Wang Q; Sun Y; Shen M; Zhu M; Wan Z; Duan Y
    J Nanosci Nanotechnol; 2012 Jun; 12(6):4467-71. PubMed ID: 22905486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EGF-modified mPEG-PLGA-PLL nanoparticle for delivering doxorubicin combined with Bcl-2 siRNA as a potential treatment strategy for lung cancer.
    Zhang X; Wang Q; Qin L; Fu H; Fang Y; Han B; Duan Y
    Drug Deliv; 2016 Oct; 23(8):2936-2945. PubMed ID: 26739487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mPEG-PLGA-b-PLL copolymer carrier for adriamycin and siRNA delivery.
    Liu P; Yu H; Sun Y; Zhu M; Duan Y
    Biomaterials; 2012 Jun; 33(17):4403-12. PubMed ID: 22436800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted delivery of tanshinone IIA-conjugated mPEG-PLGA-PLL-cRGD nanoparticles to hepatocellular carcinoma.
    Wang Y; Song D; Costanza F; Ji G; Fan Z; Cai J; Li Q
    J Biomed Nanotechnol; 2014 Nov; 10(11):3244-52. PubMed ID: 26000384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation of bufalin-loaded pluronic polyetherimide nanoparticles, cellular uptake, distribution, and effect on colorectal cancer.
    Hu Q; Liang B; Sun Y; Guo XL; Bao YJ; Xie DH; Zhou M; Duan YR; Yin PH; Peng ZH
    Int J Nanomedicine; 2014; 9():4035-41. PubMed ID: 25187707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mithramycin-loaded mPEG-PLGA nanoparticles exert potent antitumor efficacy against pancreatic carcinoma.
    Liu XJ; Li L; Liu XJ; Li Y; Zhao CY; Wang RQ; Zhen YS
    Int J Nanomedicine; 2017; 12():5255-5269. PubMed ID: 28769562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation, in vitro and in vivo evaluation of mPEG-PLGA nanoparticles co-loaded with syringopicroside and hydroxytyrosol.
    Guan Q; Sun S; Li X; Lv S; Xu T; Sun J; Feng W; Zhang L; Li Y
    J Mater Sci Mater Med; 2016 Feb; 27(2):24. PubMed ID: 26704541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methoxy poly(ethylene glycol)-poly(lactide) nanoparticles encapsulating quercetin act as an effective anticancer agent by inducing apoptosis in breast cancer.
    Sharma G; Park J; Sharma AR; Jung JS; Kim H; Chakraborty C; Song DK; Lee SS; Nam JS
    Pharm Res; 2015 Feb; 32(2):723-35. PubMed ID: 25186442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bufalin-Loaded Multifunctional Photothermal Nanoparticles Inhibit the Anaerobic Glycolysis by Targeting SRC-3/HIF-1α Pathway for Improved Mild Photothermal Therapy in CRC.
    Shang J; Xia Q; Sun Y; Wang H; Chen J; Li Y; Gao F; Yin P; Yuan Z
    Int J Nanomedicine; 2024; 19():7831-7850. PubMed ID: 39105099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation of a Thermosensitive Gel Composed of a mPEG-PLGA-PLL-cRGD Nanodrug Delivery System for Pancreatic Tumor Therapy.
    Shen M; Xu YY; Sun Y; Han BS; Duan YR
    ACS Appl Mater Interfaces; 2015 Sep; 7(37):20530-7. PubMed ID: 26366977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-circulatory nanoparticles for gemcitabine delivery: Development and investigation of pharmacokinetics and in-vivo anticancer efficacy.
    Khare V; Singh A; Mahajan G; Alam N; Kour S; Gupta M; Kumar A; Singh G; Singh SK; Saxena AK; Mondhe DM; Gupta PN
    Eur J Pharm Sci; 2016 Sep; 92():183-93. PubMed ID: 27404580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biodegradable double-targeted PTX-mPEG-PLGA nanoparticles for ultrasound contrast enhanced imaging and antitumor therapy in vitro.
    Ma J; Shen M; Xu CS; Sun Y; Duan YR; Du LF
    Oncotarget; 2016 Nov; 7(48):80008-80018. PubMed ID: 27835907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PLGA-PLL-PEG-Tf-based targeted nanoparticles drug delivery system enhance antitumor efficacy via intrinsic apoptosis pathway.
    Bao W; Liu R; Wang Y; Wang F; Xia G; Zhang H; Li X; Yin H; Chen B
    Int J Nanomedicine; 2015; 10():557-66. PubMed ID: 25609961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and in vitro/in vivo antitumor efficacy of aptamer-targeted Ecoflex
    Ghassami E; Varshosaz J; Jahanian-Najafabadi A; Minaiyan M; Rajabi P; Hayati E
    Int J Nanomedicine; 2018; 13():493-504. PubMed ID: 29416331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrasound-Mediated Microbubble Destruction (UMMD) Facilitates the Delivery of CA19-9 Targeted and Paclitaxel Loaded mPEG-PLGA-PLL Nanoparticles in Pancreatic Cancer.
    Xing L; Shi Q; Zheng K; Shen M; Ma J; Li F; Liu Y; Lin L; Tu W; Duan Y; Du L
    Theranostics; 2016; 6(10):1573-87. PubMed ID: 27446491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxicity and therapy of cisplatin-loaded EGF modified mPEG-PLGA-PLL nanoparticles for SKOV3 cancer in mice.
    Wang Y; Liu P; Qiu L; Sun Y; Zhu M; Gu L; Di W; Duan Y
    Biomaterials; 2013 May; 34(16):4068-4077. PubMed ID: 23480957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of Oxidized Low Density Lipoprotein-Induced Endothelial Cell Injury by DA-PLGA-PEG-cRGD Nanoparticles Combined with Ultrasound.
    Li Z; Huang H; Huang L; Du L; Sun Y; Duan Y
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28406431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation of poly-l-lysine-based nanoparticles with pH-sensitive release of curcumin for targeted imaging and therapy of liver cancer in vitro and in vivo.
    Yang DH; Kim HJ; Park K; Kim JK; Chun HJ
    Drug Deliv; 2018 Nov; 25(1):950-960. PubMed ID: 29658319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.